|
Sign In to gain access to subscriptions and/or personal tools.
|
Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines
Rodney L. Dunn
University of Michigan, Ann Arbor, MI, USA
John M. Donoghue
PCS Health, Liverpool, UK
Ronald J. Ozminkowski
The MEDSTAT Group, Ann Arbor, MI, USA
Deborah Stephenson
Lilly Industries, Basingstoke, UK
Timothy R. Hylan
Eli Lilly and Company, Indianapolis, IN, USA
The objective of this study was to determine whether patients beginning therapy on the most common tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) differed in their likelihood of having antidepressant treatment that was consistent with recommended treatment guidelines in the UK. An analytical file constructed from a large general practitioner medical records database (DIN-LINK) from the UK for the years 1992-97 was constructed. A total of 16 204 patients with a new episode of antidepressant therapy who initiated therapy on one of the most often prescribed TCAs (amitriptyline, dothiepin, imipramine and lofepramine) or SSRIs (fluoxetine, paroxetine and sertraline) were analysed. A dichotomous measure was defined to indicate whether subjects were prescribed at least 120 days of antidepressant therapy at an adequate average daily dose within the first 6 months after initiation of therapy. Only 6.0% of patients initiating therapy on aTCA and 32.9% of patients initiating therapy on a SSRI were prescribed antidepressant treatment that was consistent with treatment guidelines. After controlling for observable characteristics, patients who initiated therapy on a SSRI were much more likely (odds ratio=7.473, p<0.001) to have a prescribed average daily dose and duration consistent with recommended treatment guidelines within the first 6 months of initiating therapy than were patients who initiated therapy on a TCA. These findings suggest that initial antidepressant selection is an important determinant of whether the subsequent course of treatment is consistent with current national guidelines for the treatment of depression in the UK.
Key Words: antidepressants • depression • drug prescribing patterns • selective serotonin reuptake inhibitors • tricyclic antidepressants
Journal of Psychopharmacology, Vol. 13, No. 2,
136-143 (1999)
DOI: 10.1177/026988119901300204
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Moore, H. M. Yuen, N. Dunn, M. A Mullee, J. Maskell, and T. Kendrick
Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database
BMJ,
October 15, 2009;
339(oct15_2):
b3999 - b3999.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Weze, H. L. Leathard, J. Grange, P. Tiplady, and G. Stevens
Healing by Gentle Touch Ameliorates Stress and Other Symptoms in People Suffering with Mental Health Disorders or Psychological Stress
Evid. Based Complement. Altern. Med.,
March 1, 2007;
4(1):
115 - 123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Olfson, S. C. Marcus, M. Tedeschi, and G. J. Wan
Continuity of Antidepressant Treatment for Adults With Depression in the United States
Am J Psychiatry,
January 1, 2006;
163(1):
101 - 108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Joo, F. X. Solano, B. H. Mulsant, C. F. Reynolds, and E. J. Lenze
Predictors of Adequacy of Depression Management in the Primary Care Setting
Psychiatr Serv,
December 1, 2005;
56(12):
1524 - 1528.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Hansen, W. Vach, J.-U. Rosholm, J. Sondergaard, L. F Gram, and J. Kragstrup
Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics
Fam. Pract.,
December 1, 2004;
21(6):
623 - 629.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. CHEETA, F. SCHIFANO, A. OYEFESO, L. WEBB, and A. H. GHODSE
Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000
The British Journal of Psychiatry,
January 1, 2004;
184(1):
41 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Wilson, J. E. Bailey, C. Alford, A. Weinstein, and D. J. Nutt
Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood
J Psychopharmacol,
July 1, 2002;
16(4):
321 - 331.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Charlier, E. Pinto, M. Ansseau, and G. Plomteux
Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients.
J Psychopharmacol,
July 1, 2002;
16(4):
369 - 372.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. DONOGHUE and T. R. HYLAN
Antidepressant use in clinical practice: efficacy v. effectiveness
The British Journal of Psychiatry,
September 1, 2001;
179
(42):
s9 - s17.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. I. Alterman, J. Langenbucher, and R. L. Morrison
State-Level Treatment Outcome Studies Using Administrative Databases
Eval Rev,
April 1, 2001;
25(2):
162 - 183.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Valenstein, S. Vijan, J. E. Zeber, K. Boehm, and A. Buttar
The Cost-Utility of Screening for Depression in Primary Care
Ann Intern Med,
March 6, 2001;
134(5):
345 - 360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Peveler and T. Kendrick
Treatment delivery and guidelines in primary care: Depression and public health
Br. Med. Bull.,
March 1, 2001;
57(1):
193 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kendrick
Depression management clinics in general practice?
BMJ,
February 26, 2000;
320(7234):
527 - 528.
[Full Text]
|
|
|
|
|
|
|
T. Kendrick
Why can't GPs follow guidelines on depression?
BMJ,
January 22, 2000;
320(7229):
200 - 201.
[Full Text]
|
|
|
|
|
|
|
I. M. Anderson, D. J. Nutt, and J. F. W. Deakin
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
J Psychopharmacol,
January 1, 2000;
14(1):
3 - 20.
[Abstract]
[PDF]
|
|
|
|
|
